BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 3, 2026
See today's BioWorld MedTech
Home
» GE Healthcare beats earnings estimates in first year as standalone company
To read the full story,
subscribe
or
sign in
.
GE Healthcare beats earnings estimates in first year as standalone company
Feb. 9, 2024
By
Holland Johnson
In its first full year since its spin-off from parent company General Electric Co., GE Healthcare Technologies Inc. reported beating Wall Street’s expectations. For 2023, revenues of $19.6 billion grew 8% organically vs. 2022.
Medical technology
Earnings